包邮心脏病学-第2版

内容简介

本书是科学性的集中体现，无论在篇章设置、概念引用、文字表达，还是图表运用上都秉承严肃认真的科学态度，进行了合理的安排与控制。已成为美国广大医学生和住院医师获取专业知识的*佳读物，深受广大读者的喜爱，已被打造成为高质量、值得信赖的品牌书。
本书采用英中文对照的形式，在获得丰富医学知识的同时还可以提高专业英语水平，可供医学生、住院医师、全科医师学习阅读，也可作为专科医生参考用书。

节选

相关资料

插图：Once stabilized, all survivors of SCD should undergo echocardiography to seek evidence of CAD or valvular heart disease and to determine the LVEE Patients with normal LV function but with risk factors for CAD should undergo diagnostic exercise stress testing. In patients with a depressed EF, cardiac catheterization may be warranted to exclude significant underlying CAD, and EPS may be indicated for risk stratification and guidance of therapy.TreatmentThe initial management of survivors of SCD is in large part supportive, with most requiring intubation and mechanical ventilation for several days. Hemodynamic lability is common, as are CHF, recurrent arrhythmias, and infection （especially aspiration pneumonia）. Most survivors are neurologically impaired following the event but have neurologic recovery （albeit often incomplete recovery） over the course of several days. Hypothermic therapy has been shown to improve overall neurologic outcome following SCD and should be instituted in patients who remain unresponsive after resuscitation. Hypothermia is achieved via cooling blankets or intravascular cooling devices. The patient's temperature should be reduced to 32 to 34℃ for 24 hours, after which passive warming is allowed. Patients must be sedated, and pharmacologic paralysis is required during hypothermia to prevent shivering.The specific treatment of survivors of SCD depends on the etiology of the event. If a reversible cause is identified （e.g., medication toxicity or electrolyte abnormality）, treatment involves correcting the underlying problem. However, if the patient is thought to have suffered an acute ischemic event as the basis for SCD, cardiac catheterization should be performed and percutaneous or surgical revascularization undertaken if possible. Implantation of an ICD should be strongly considered in all SCD survivors who have had a previous MI or have an underl

作者简介

译者简介：
赵世光，中共党员，主任医师，教授，博士生导师，博士后指导教师。现任哈尔滨医科大学附属**医院神经外科主任，哈尔滨医科大学附属**医院副院长。
中华医学会神经外科分会常委，中国医师协会神经外科分会常委，中国康复医学会创伤康复专业委员会副主任委员，中国抗癌协会中国神经肿瘤学会副主任委员，黑龙江省医学会神经外科专业委员会主任委员，黑龙江省医师协会神经外科专业委员会主任委员，黑龙江省神经科学学会神经外科分会主任委员，黑龙江省博士学术研究会医学专业委员会副主任委员，国家自然科学基金评审专家，美国神经外科医师协会（AANS）会员，亚太地区神经外科学会会员，日本国际脑肿瘤病理学会会员。
《Brain Tumor Pathology》国际编委，《中国神经肿瘤杂志》副主编，《中华神经外科疾病研究杂志》、《中华神经医学杂志》、《中国临床神经外科杂志》、《中国微侵袭神经外科杂志》、《中国急救医学杂志》、《中华脑血管病杂志》编委，《European Journal of Cancer》、《中华医学杂志英文版》、《中华神经外科杂志》特约审稿专家。
曾获教育部提名国家科技进步二等奖、黑龙江省高校科学技术奖二等奖、黑龙江省人民政府科学技术进步二等奖、黑龙江省医药卫生科技进步一等奖、黑龙江省卫生厅科技进步一等奖等国家、省部级奖励共18项。
曾承担国家973计划前期研究专项、国家自然科学基金等国家、省部级各类课题20余项。获国家发明专利4项。在国际、国内等核心期刊发表论文100余篇（其中SCI收录18篇）。